| Sign In to gain access to subscriptions and/or personal tools. |
DOI: 10.1177/1545968305277219
New Therapeutic Approaches to Parkinsons Disease Including Neural TransplantsCambridge Centre for Brain Repair
Cambridge Centre for Brain Repair, Department of Neurology, Cambridge University, Cambridge, UK, Edith Cowan University, Perth, Australia, rab46{at}hermes.cam.ac.uk Parkinsons disease (PD) is a common neurodegenerative disorder of the brain and typically presents with a disorder of movement. The core pathological event underlying the condition is the loss of the dopaminergic nigrostriatal pathway with the formation of alpha-synuclein positive Lewy bodies. As a result, drugs that target the degenerating dopaminergic network within the brain work well at least in the early stages of the disease. Unfortunately, with time these therapies fail and produce their own unique side-effect profile, and this, coupled with the more diffuse pathological and clinical findings in advancing disease, has led to a search for more effective therapies. In this review, the authors will briefly discuss the emerging new drug therapies in PD before concentrating on a more detailed discussion on the state of cell therapies to cure PD.
Key Words: Parkinsons disease Drug therapies Cell transplantation
This article has been cited by other articles:
|
|||||||||||||
